Phase-Regulated Sensing Mechanism of MoS2 Based Nanohybrids toward Point-of-Care Prostate Cancer Diagnosis
- 1 May 2020
- Vol. 16 (18), 2000307
- https://doi.org/10.1002/smll.202000307
Abstract
Alpha-methylacyl-CoA racemase (AMACR) has been proven to be consistently overexpressed in prostate cancer epitheliums, and is expected to act as a positive biomarker for the diagnosis of prostate carcinoma in clinical practice. Here, a strategy for specific determination of AMACR in real human serum by using an electrochemical microsensor system is presented. In order to implement the protocol, a self-organized nanohybrid consisting of metal nanopillars in a 2D MoS2 matrix is developed as material for the sensing interface. The testing signal outputs are strongly enhanced with the presence of the nanohybrids owing to that the metal pillars provide an efficient mass difussion and electron transfer path to the MoS2 film surface. Furthermore, the phase-regulated sensing mechanism over MoS2 is noticed and demonstrated by density functional theory calculation and experiments. The explored MoS2 based nanohybrids are employed for the fabrication of an electrochemical microsensor, presenting good linear relationship in both ng mu L-1 and pg mu L-1 ranges for AMACR quantification. The sampling analysis of human serum indicates that this microsensor has good diagnostic specificity and sensitivity toward AMACR. The proposed electrochemical microsensor system also demonstrates the advantages of convenience, cost-effectiveness, and disposability, resulting in a potential integrated microsystem for point-of-care prostate cancer diagnosis.Funding Information
- National Natural Science Foundation of China (61527818, 61604163)
- National Science Foundation (17ZR1410000, 18ZR1415400)
- Chinese Academy of Sciences (QYZDJ‐SSW‐JSC001)
This publication has 56 references indexed in Scilit:
- Semen AMACR protein as a novel method for detecting prostate cancerUrologic Oncology, 2018
- A novel colorimetric assay for α-methylacyl-CoA racemase 1A (AMACR; P504S) utilizing the elimination of 2,4-dinitrophenolateChemical Communications, 2017
- High alpha-methylacyl-CoA racemase (AMACR) is associated with ERG expression and with adverse clinical outcome in patients with localized prostate cancerTumor Biology, 2016
- Horseradish peroxidase and aptamer dual-functionalized nanoprobe for the amplification detection of alpha-methylacyl-CoA racemaseAnalytica Chimica Acta, 2015
- Selection of aptamers for fluorescent detection of alpha-methylacyl-CoA racemase by single-bead SELEXBiosensors and Bioelectronics, 2014
- Detection of Alpha-Methylacyl-CoA Racemase (AMACR), a Biomarker of Prostate Cancer, in Patient Blood Samples Using a Nanoparticle Electrochemical BiosensorBiosensors, 2012
- Emerging Biomarkers for the Diagnosis and Prognosis of Prostate CancerClinical Chemistry, 2008
- New circulating biomarkers for prostate cancerProstate Cancer and Prostatic Diseases, 2007
- Expression of α-methylacyl-coa racemase (p504s) in various malignant neoplasms and normal tissues: a study of 761 casesHuman Pathology, 2003
- Overdiagnosis Due to Prostate-Specific Antigen Screening: Lessons From U.S. Prostate Cancer Incidence TrendsJNCI Journal of the National Cancer Institute, 2002